Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010620 · ClinicalTrials.gov registry record
Screening Protocol for Research Participants
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 523
- Enrollment target
NCT01010620: Completed study, sponsored by University of Maryland, Baltimore.
NCT01010620 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 523 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01010620 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 523 participants
- Enrollment target
Study Summary
The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.
Interventions
- BEHAVIORAL Various Screening psychiatric and medical assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 523 participants |
| Start Date | 2009-12 |
| Est. Completion | 2019-06-01 |
What the finished NCT01010620 record still lists
NCT01010620 is an observational study that tracks outcomes without assigning an intervention. The registered 523 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Various Screening psychiatric and medical assessments is the first listed.
NCT01010620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01010620 about?
NCT01010620 is a clinical study titled "Screening Protocol for Research Participants". The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.
What is the current status of trial NCT01010620?
This trial is currently completed. The enrollment target is 523 participants. The study started on 2009-12. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT01010620?
The interventions under investigation include: Various Screening psychiatric and medical assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT01010620?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03526835 · 523 participants · Phase 1
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- NCT04580134 · 524 participants · Phase 4
CLOZAPINE Response in Biotype-1
- NCT07158814 · 524 participants · Phase 4
Safety of RSV Preventive Monoclonal Antibody
- NCT06835686 · 522 participants · NA
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia